Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1/2 Study of SB1518 for the Treatment of Advanced Myeloid Malignancies

NCT00719836 is registered in ClinicalTrials.gov with S*BIO as lead sponsor.

NCT NCT00719836
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00719836 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1/2 Study of SB1518 for the Treatment of Advanced Myeloid Malignancies
Lead sponsor
S*BIO
Phase
Phase 1/2
Overall status
Completed
Start date
August 31, 2008
Completion date
January 31, 2012
Enrollment
76 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

acute myelogenous leukemia, chronic myelogenous leukemia, chronic myelomonocytic leukemia, myelodysplastic syndromes, myelofibrosis